Roche Reports 7% Sales Growth to CHF 61.5B, Driven by Pharma and China
Roche (SWX: ROG, OTCMKTS: RHHBY) reported full‑year 2025 sales of CHF 61.5 billion : (USD 69.1 billion), representing 7% growth at...
RDL
NHSA 2025 Drug Lists Add 114 Medical Insurance Drugs, 19 Commercial
The National Healthcare Security Administration (NHSA) released the 2025 National Medical Insurance Drug List and...
NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks
The National Healthcare Security Administration (NHSA) wrapped up a week‑long series of negotiations and bidding...
NHSA Completes 2025 Drug Negotiation Review; CAR‑T Therapies Clear the Hurdle
The National Healthcare Security Administration (NHSA) announced today that the expert review for the 2025...
China’s NHSA Publishes Preliminary List for 2025 National Reimbursement Drug List and Commercial Insurance Innovative Drug List
China’s National Healthcare Security Administration (NHSA) released the preliminary formal review results for the 2025...
China’s Healthcare Bureaus Remove Drug Quantity Limits to Enhance NRDL Access
The healthcare security administration bureaus in Shanghai, Beijing, and other regions have recently removed limits...
Beijing Releases List of Novel Drugs and Technologies Exempt from CHS-DRG Payment Scheme
The Beijing Municipal Medical Insurance Bureau has released the list of the first batch of...
NHSA to Announce NRDL Adjustment Results at November 28th Press Conference
The National Healthcare Security Administration (NHSA) will unveil the results of the negotiation and price...
China’s NHSA Concludes Pre-Negotiation Talks for National Reimbursement Drug List
According to the Economic Observer, an independent Chinese weekly newsletter, a series of discussions preceding...
NHSA Updates NRDL Review, Adds Three Domestic Western Medicines
The National Healthcare Security Administration (NHSA) has issued a notification regarding the review and correction...
Beijing Unveils Action Plan to Boost Pharmaceutical and Health Industry by 2026
The Beijing People’s Government has issued an “Action Plan” outlining measures and targets to “Accelerate...
GSK Posts 5% YOY Growth in 2023 Financials, Vaccines Business Drives Expansion
GSK plc (NYSE: GSK), the UK pharmaceutical giant, announced its financial results for the fourth...
Hunan Province Hospitals Commit to Implementing Nationally Negotiated Drugs in Policy Seminar
A policy seminar under the auspices of the Hunan Healthcare Security Administration bureau convened in...
EU Chamber of Commerce in China Releases Position Paper, Addresses Pharma and Healthcare
The EU Chamber of Commerce in China has released its bi-annual “European Business in China...
NHSA Releases Official Guidelines for Drug Negotiations and Bidding for NRDL Update
The National Healthcare Security Administration (NHSA) has officially released the “Negotiation Drug Renewals” and “Non-exclusive...
NHSA Unveils 2023 Work Plan for National Reimbursement Drug List Update
The National Healthcare Security Administration (NHSA) has released the “Work Plan for the National Reimbursement...
Anhui and Qinghai Provinces Update BMI Chronic Disease Drug Lists for Outpatient Reimbursement
The healthcare security bureaus of Anhui and Qinghai provinces in China have separately released notifications...
China’s Premier Li Keqiang Highlights Economic and Social Advances in Annual Report
Premier Li Keqiang delivered his annual Government Work Report at the “Two Sessions” meeting, which...
China’s NRDL Update and Expansion of ‘Dual Channel’ Drug Access
The latest update to China’s National Reimbursement Drug List (NRDL) was implemented from March 1,...
China’s NRDL Update: New Drugs Available for Online Procurement
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) drug procurement platform has released a notice stating that...